NZ215696A - Fusogenic phospholipid vesicles - Google Patents

Fusogenic phospholipid vesicles

Info

Publication number
NZ215696A
NZ215696A NZ215696A NZ21569686A NZ215696A NZ 215696 A NZ215696 A NZ 215696A NZ 215696 A NZ215696 A NZ 215696A NZ 21569686 A NZ21569686 A NZ 21569686A NZ 215696 A NZ215696 A NZ 215696A
Authority
NZ
New Zealand
Prior art keywords
phospholipid vesicles
fusogenic phospholipid
fusogenic
vesicles
phospholipid
Prior art date
Application number
NZ215696A
Other languages
English (en)
Inventor
A G Gitman
A Loyter
Original Assignee
Int Genetic Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Genetic Sciences filed Critical Int Genetic Sciences
Publication of NZ215696A publication Critical patent/NZ215696A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ215696A 1985-04-04 1986-04-03 Fusogenic phospholipid vesicles NZ215696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71986285A 1985-04-04 1985-04-04

Publications (1)

Publication Number Publication Date
NZ215696A true NZ215696A (en) 1989-07-27

Family

ID=24891665

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ215696A NZ215696A (en) 1985-04-04 1986-04-03 Fusogenic phospholipid vesicles

Country Status (16)

Country Link
JP (1) JPS61274739A (fr)
AU (1) AU585330B2 (fr)
BE (1) BE904536A (fr)
BR (1) BR8601554A (fr)
CA (1) CA1262863A (fr)
CH (1) CH668005A5 (fr)
DE (1) DE3610873A1 (fr)
ES (1) ES8802401A1 (fr)
FR (1) FR2579891B1 (fr)
GB (1) GB2188900B (fr)
IL (1) IL78348A (fr)
IT (1) IT1189877B (fr)
NL (1) NL8600794A (fr)
NZ (1) NZ215696A (fr)
SE (1) SE464448B (fr)
ZA (1) ZA862466B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550289A (en) * 1985-01-07 1996-08-27 Syntex (U.S.A.) Inc. N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
JPS63275522A (ja) * 1987-05-01 1988-11-14 Terumo Corp 人工赤血球及びその製造方法
JPH04283207A (ja) * 1991-03-13 1992-10-08 Kao Corp ベシクル及び重合体ベシクル
CA2269631C (fr) * 1996-10-25 2008-03-25 Monsanto Company Composition permettant de traiter des vegetaux avec des substances chimiques exogenes et technique afferente
AU4998997A (en) * 1996-10-25 1998-05-15 Monsanto Company Composition and method for treating plants with exogenous chemicals
WO2013039994A2 (fr) * 2011-09-12 2013-03-21 Cure Pharmaceutical Corp. Appareil, composition et procédés associés servant à administrer par voie transdermique des principes actifs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
EP0187702B1 (fr) * 1985-01-07 1990-03-14 Syntex (U.S.A.) Inc. Composés tensioactifs de N-(oméga, oméga-1-dialkoxy)- et N-(oméga, oméga-1-dialcénoxy)-alkyl-1 ammonium N,N,N-trisubstitué, leur préparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CH668005A5 (de) 1988-11-30
FR2579891A1 (fr) 1986-10-10
CA1262863A (fr) 1989-11-14
IL78348A0 (en) 1986-07-31
IL78348A (en) 1989-08-15
GB8608468D0 (en) 1986-05-14
JPS61274739A (ja) 1986-12-04
SE8601408D0 (sv) 1986-03-26
AU585330B2 (en) 1989-06-15
GB2188900B (en) 1990-04-04
ZA862466B (en) 1986-11-26
BR8601554A (pt) 1986-12-09
BE904536A (fr) 1986-07-31
IT1189877B (it) 1988-02-10
FR2579891B1 (fr) 1990-02-02
AU5562286A (en) 1986-10-09
GB2188900A (en) 1987-10-14
NL8600794A (nl) 1986-11-03
IT8683340A0 (it) 1986-04-03
SE8601408L (sv) 1986-10-05
SE464448B (sv) 1991-04-29
ES553703A0 (es) 1988-05-16
ES8802401A1 (es) 1988-05-16
DE3610873A1 (de) 1986-10-09

Similar Documents

Publication Publication Date Title
PT81242A (en) Steroidal liposomes
AU1107988A (en) Liposomes with enhanced circulation time
GB2177092B (en) New amphiphilic lipid compounds
GB8627747D0 (en) Oxygenator
EP0186352A3 (en) Preparation of lipid vesicles
GB8607817D0 (en) Drug preparation
GB8721108D0 (en) Liposomes
EP0365050A3 (en) Combined machine
GB2177004B (en) Fumigation
NZ215696A (en) Fusogenic phospholipid vesicles
EP0160286A3 (en) Liposomes
GB8504523D0 (en) Biscuit cutter
GB8605385D0 (en) Rotors
GB2186877B (en) Phospholipids
GB8513715D0 (en) Rotors
GB8524486D0 (en) Framework
PH25705A (en) Steroidal liposomes
PH24644A (en) Steroidal liposomes
GB8620716D0 (en) Medicament
GB8514702D0 (en) High entrapment vesicles
GB8621047D0 (en) Liposomes
ZA881763B (en) Paucilamellar lipid vesicles
IE841667L (en) Therapeutic phospholipids
GB8507306D0 (en) Therpeutic agents
ZA862086B (en) Hammermill